Cramer’s lightning round: Vir and GlaxoSmithKline 'may have something' that could fight omicron

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.